FCM
INBX

Farallon Capital Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Farallon Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-569,328
Closed -$15.7M – 333
2021
Q2 		$15.7M Sell
569,328
-30,672
-5% -$639K 0.06% 109
2021
Q1 		$12M Buy
600,000
+90,000
+18% +$2.63M 0.06% 127
2020
Q4 		$16.8M Buy
510,000
+115,000
+29% +$3.06M 0.1% 94
2020
Q3 		$7.11M Buy
+395,000
New +$7.16M 0.05% 104

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Farallon Capital Management's INBX Position: Q3 2021 in Review

Farallon Capital Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q3 2021, closing a stake of 569,328 shares — an estimated $15.7M sold.

Farallon Capital Management first reported a position in INBX in Q3 2020 and held it in 4 quarters. The position peaked at $16.8M in Q4 2020. 66 funds tracked by Wall St. Rank hold INBX as of Q3 2021.

  • Farallon Capital Management reported no remaining Inhibrx, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Farallon Capital Management sold 569,328 Inhibrx, Inc. Common Stock shares in Q3 2021, an estimated $15.7M.
  • Farallon Capital Management first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Farallon Capital Management's Inhibrx, Inc. Common Stock position peaked at $16.8M in Q4 2020.
  • 66 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q3 2021.

Based on Farallon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.